3.8 Review

Systematic review of social prescribing and older adults: where to from here?

期刊

FAMILY MEDICINE AND COMMUNITY HEALTH
卷 10, 期 SUPPL_1, 页码 -

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/fmch-2022-001829

关键词

-

资金

  1. Canada Research Chairs Program

向作者/读者索取更多资源

Social prescribing is a person-centred model of care that aims to address unmet social needs and reduce non-medical resource use in primary care. This systematic review aimed to examine the impact of social prescribing for older adults. The review included seven studies and found some positive effects on physical and psychosocial outcomes, but varied results for health resource use. However, there is a lack of peer-reviewed studies on social prescribing for older adults, and further research is needed to determine its effectiveness and feasibility.
Objective Social prescribing is a person-centred model of care with emphases on lessening the impact of unmet social needs, supporting the delivery of personalised care, and reducing non-medical resource use in the primary care setting. The purpose of this systematic review was to synthesise the effect of social prescribing for older adults within primary care. Design We followed standard systematic review guidelines, including protocol registration, screening studies (title/abstract and full text) and assessing the study quality. Eligibility and information sources We searched multiple online databases for studies that included older adults 60+ years (group mean age), an intervention defined and called social prescribing (or social prescription) via health provider referrals to non-medical services, and quantitative physical and psychosocial outcomes and/or health resource use. We included experimental and observational studies from all years and languages and conducted a narrative synthesis. The date of the last search was 24 March 2022. Results We screened 406 citations (after removing duplicates) and included seven studies. All studies except one were before-after design without a control group, and all except one study was conducted in the UK. Studies included 12-159 participants (baseline), there were more women than men, the group mean (SD) age was 76.1 (4.0) years and data collection (baseline to final) occurred on average 19.4 (14.0) weeks apart. Social prescribing referrals came from health and social providers. Studies had considerable risk of bias, programme implementation details were missing, and for studies that reported data (n=6) on average only 66% of participants completed studies (per-protocol). There were some positive effects of social prescribing on physical and psychosocial outcomes (eg, social participation, well-being). Findings varied for health resource use. These results may change with new evidence. Conclusions There were few peer-reviewed studies available for social prescribing and older adults. Next steps for social prescribing should include co-creating initiatives with providers, older people and communities to identify meaningful outcomes, and feasible and robust methods for uptake of the prescription and community programmes. This should be considered in advance or in parallel with determining its effectiveness for meaningful outcomes at multiple levels (person, provider and programme).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据